[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +15%
1 Month: XX% +12%
6 Months: XX% +19%
1 Year: XX% +17%
1-Year High: XX% on 2024-11-03
1-Year Low: XX% on 2025-05-31
Most Supportive Themes
- Positive Clinical Trial Results and Wegovy's Cardiovascular Benefits: (35%) Posts highlighting positive results from clinical trials for Novo Nordisk's drugs, particularly Wegovy, and its cardiovascular benefits.
- Long-Term Growth Potential and Valuation: (25%) Posts discussing the long-term growth potential of Novo Nordisk, especially in the obesity and diabetes markets, and its current valuation.
- Expert Analysis and Recommendations: (15%) Posts from analysts and financial experts recommending Novo Nordisk as a buy or highlighting its strengths.
Most Critical Themes
- Competition and Market Share Concerns: (20%) Posts expressing concerns about increasing competition from other pharmaceutical companies, particularly Eli Lilly, and its impact on Novo Nordisk's market share.
- Negative Guidance and Restructuring: (5%) Posts discussing the company's lowered sales and operating profit outlook, job cuts, and restructuring efforts.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXXXX | XX% | XXXXXXX | XX% | XXXXXX | X% |
| TikTok | XXX | X% | XXXXXX | XX% | XXXXXX | X% |
| YouTube | XXXXX | X% | XXX | X% | XX | X% |
| XX | X% | X | X% | X | X% | |
| Total | XXXXXXX | XX% | XXXXXXX | XX% | XXXXXX | X% |